Michael N. Liebman, Ph.D, Executive Director

Windber Research Institute


Bio

Michael N. Liebman, Ph.D. is executive Director of the Windber Research Institute after serving as Chief Scientific Officer since November, 2003. Prior to this he was Director, Computational Biology and Biomedical Informatics at the Abramson Family Cancer Research Institute of the University of Pennsylvania Cancer Center since September, 2000. He previously was Global Head of Computational Genomics at Roche Pharmaceuticals and Director, Bioinformatics and Pharmacogenomics at Wyeth Pharmaceuticals. He was also Director of Genomics for Vysis, Inc and Director of Bioinformatics at the Amoco Technology Company. He has served on the faculty of Mount Sinai School of Medicine in Pharmacology and hysiology/Bipohysics. He serves on 12 international scientific advisory boards consults for 5 pharma/biotech companies and has been on the economic development programs in the Philadelphia Life Sciences Sector and the State of Illinois Biotechnology Commission. He is currently Chair of the Healthcare Task Force for the SMART program, and on the Human Health and Medicinal Chemistry Commission of the IUPAC. His research focuses on computational models of disease progression stressing risk detection, disease process modeling and analysis of lifestyle interactions